These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2343460)
1. Inhibition of rat heart mitochondrial electron transport in vitro: implications for the cardiotoxic action of allylamine or its primary metabolite, acrolein. Biagini RE; Toraason MA; Lynch DW; Winston GW Toxicology; 1990 May; 62(1):95-106. PubMed ID: 2343460 [TBL] [Abstract][Full Text] [Related]
2. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart. Toraason M; Luken ME; Breitenstein M; Krueger JA; Biagini RE Toxicology; 1989 May; 56(1):107-17. PubMed ID: 2728003 [TBL] [Abstract][Full Text] [Related]
3. Allylamine cardiotoxicity--IV. Metabolism to acrolein by cardiovascular tissues. Nelson TJ; Boor PJ Biochem Pharmacol; 1982 Feb; 31(4):509-14. PubMed ID: 7066019 [TBL] [Abstract][Full Text] [Related]
4. Allylamine and acrolein toxicity in perfused rat hearts. Sklar JL; Anderson PG; Boor PJ Toxicol Appl Pharmacol; 1991 Mar; 107(3):535-44. PubMed ID: 2000639 [TBL] [Abstract][Full Text] [Related]
5. The role of glutathione S-transferases as a defense against reactive electrophiles in the blood vessel wall. He NG; Awasthi S; Singhal SS; Trent MB; Boor PJ Toxicol Appl Pharmacol; 1998 Sep; 152(1):83-9. PubMed ID: 9772203 [TBL] [Abstract][Full Text] [Related]
6. Effect of furosemide on mitochondrial electron transport system and oxidative phosphorylation. Orita Y; Fukuhara Y; Yanase M; Ando A; Okada N; Abe H Arzneimittelforschung; 1983; 33(10):1446-50. PubMed ID: 6316993 [TBL] [Abstract][Full Text] [Related]
7. Allylamine cardiovascular toxicity: VI. Subcellular distribution in rat aortas. Hysmith RM; Boor PJ Toxicology; 1985 Jun; 35(3):179-87. PubMed ID: 2990070 [TBL] [Abstract][Full Text] [Related]
8. Comparative toxicity of 4-chlorobiphenyl and its metabolite 4-chloro-4'-biphenylol in isolated rat liver mitochondria. Nishihara Y Biochem Pharmacol; 1988 Aug; 37(15):2915-26. PubMed ID: 2969244 [TBL] [Abstract][Full Text] [Related]
11. Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity. Conklin DJ; Langford SD; Boor PJ Toxicol Sci; 1998 Dec; 46(2):386-92. PubMed ID: 10048142 [TBL] [Abstract][Full Text] [Related]
12. Biochemical effects of PR toxin on rat liver mitochondrial respiration and oxidative phosphorylation. Wei YH; Ding WH; Wei RD Arch Biochem Biophys; 1984 May; 230(2):400-11. PubMed ID: 6324685 [TBL] [Abstract][Full Text] [Related]
13. Sites of inhibition of mitochondrial electron transport by rhein. Floridi A; Castiglione S; Bianchi C Biochem Pharmacol; 1989 Mar; 38(5):743-51. PubMed ID: 2522779 [TBL] [Abstract][Full Text] [Related]
14. Studies of practolol on mitochondrial metabolism. Oliveira TC; Fortes JC; Lopes LC; Campello AP Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):141-8. PubMed ID: 7403672 [TBL] [Abstract][Full Text] [Related]
15. Binding of [14C] allylamine to isolated mitochondria from rat heart and aorta. Hysmith RM; Boor PJ Toxicology; 1987 Apr; 44(1):13-29. PubMed ID: 3105119 [TBL] [Abstract][Full Text] [Related]
16. Influence of ubiquinone on the inhibitory effect of adriamycin on mitochondrial oxidative phosphorylation. Muhammed H; Kurup CK Biochem J; 1984 Jan; 217(2):493-8. PubMed ID: 6696744 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the mitochondrial Mg2+-ATPase by propranolol. Wei YH; Lin TN; Hong CY; Chiang BN Biochem Pharmacol; 1985 Apr; 34(7):911-7. PubMed ID: 3157382 [TBL] [Abstract][Full Text] [Related]